Full text
PDF![865](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/695fcc7dd6a5/jcinvest00264-0079.png)
![866](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/5247efabc065/jcinvest00264-0080.png)
![867](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/f57ae2ce2c17/jcinvest00264-0081.png)
![868](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/9401ece025a0/jcinvest00264-0082.png)
![869](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/250922707a6a/jcinvest00264-0083.png)
![870](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/901135514659/jcinvest00264-0084.png)
![871](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/c46c94e9d7aa/jcinvest00264-0085.png)
![872](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/0ed3c87737d6/jcinvest00264-0086.png)
![873](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/49b70260eb44/jcinvest00264-0087.png)
![874](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/091ee13cf157/jcinvest00264-0088.png)
![875](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/ab740927393c/jcinvest00264-0089.png)
![876](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/eeded20b6c07/jcinvest00264-0090.png)
![877](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/207b222363a1/jcinvest00264-0091.png)
![878](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/30439a512d89/jcinvest00264-0092.png)
![879](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ef/292766/2ddd904ce19a/jcinvest00264-0093.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AMES R. P., BORKOWSKI A. J., SICINSKI A. M., LARAGH J. H. PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES. J Clin Invest. 1965 Jul;44:1171–1186. doi: 10.1172/JCI105224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BARTTER F. C., PRONOVE P., GILL J. R., Jr, MACCARDLE R. C. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 1962 Dec;33:811–828. doi: 10.1016/0002-9343(62)90214-0. [DOI] [PubMed] [Google Scholar]
- BLAIR-WEST J. R., COGHLAN J. P., DENTON D. A., GODING J. R., MUNRO J. A., PETERSON R. E., WINTOUR M. Humoral stimulation of adrenal cortical secretion. J Clin Invest. 1962 Aug;41:1606–1627. doi: 10.1172/JCI104619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BROWN J. J., DAVIES D. L., LEVER A. F., ROBERTSON J. I. Influence of sodium loading and sodium depletion on plasma-renin in man. Lancet. 1963 Aug 10;2(7302):278–279. doi: 10.1016/s0140-6736(63)90176-4. [DOI] [PubMed] [Google Scholar]
- BROWN J. J., DAVIES D. L., LEVER A. F., ROBERTSON J. I. VARIATIONS IN PLASMA RENIN CONCENTRATION IN SEVERAL PHYSIOLOGICAL AND PATHOLOGICAL STATES. Can Med Assoc J. 1964 Jan 25;90:201–206. [PMC free article] [PubMed] [Google Scholar]
- Biron P., Koiw E., Nowaczynski W., Brouillet J., Genest J. THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE. J Clin Invest. 1961 Feb;40(2):338–347. doi: 10.1172/JCI104261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CANNON P. J., WHITLOCK R. T., MORRIS R. C., ANGERS M., LARAGH J. H. Effect of alpha-methyl DOPA in severe and malignant hypertension. JAMA. 1962 Mar 3;179:673–681. doi: 10.1001/jama.1962.03050090001001. [DOI] [PubMed] [Google Scholar]
- CONN J. W. PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION. JAMA. 1964 Oct 19;190:222–225. [PubMed] [Google Scholar]
- DAVIS J. O., HARTROFT P. M., TITUS E. O., CARPENTER C. C., AYERS C. R., SPIEGEL H. E. The role of the renin-angiotensin system in the control of aldosterone secretion. J Clin Invest. 1962 Feb;41:378–389. doi: 10.1172/JCI104492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DAVIS J. O., URQUHART J., HIGGINS J. T., Jr The effects of alteration of plasma sodium and potassium concentration on aldosterone secretion. J Clin Invest. 1963 May;42:597–609. doi: 10.1172/JCI104750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DENTON D. A., GODING J. R., WRIGHT R. D. Control of adrenal secretion of electrolyte-active steroids; adrenal stimulation by cross-circulation experiments in conscious sheep. Br Med J. 1959 Sep 26;2(5151):522–530. doi: 10.1136/bmj.2.5151.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FALBRIARD A., MULLER A. F., NEHER R., MACH R. S. Etude des variations de l'aldostéronurie sous l'effet de surcharges en potassium et de déperditions rénales et extrarenales de sel et d'eau. Schweiz Med Wochenschr. 1955 Dec 10;85(50):1218–1220. [PubMed] [Google Scholar]
- GANN D. S., CRUZ J. F., CASPER A. G., BARTTER F. C. Mechanism by which potassium increases aldosterone secretion in the dog. Am J Physiol. 1962 May;202:991–996. doi: 10.1152/ajplegacy.1962.202.5.991. [DOI] [PubMed] [Google Scholar]
- GANN D. S., DELEA C. S., GILL J. R., Jr, THOMAS J. P., BARTTER F. C. CONTROL OF ALDOSTERONE SECRETION BY CHANGE OF BODY POTASSIUM IN NORMAL MAN. Am J Physiol. 1964 Jul;207:104–108. doi: 10.1152/ajplegacy.1964.207.1.104. [DOI] [PubMed] [Google Scholar]
- JOHNSON B. B., LIEBERMAN A. H., MULROW P. J. Aldosterone excretion in normal subjects depleted of sodium and potassium. J Clin Invest. 1957 Jun;36(6 Pt 1):757–766. doi: 10.1172/JCI103480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LARAGH J. H., ANGERS M., KELLY W. G., LIEBERMAN S. Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. JAMA. 1960 Sep 17;174:234–240. doi: 10.1001/jama.1960.03030030014003. [DOI] [PubMed] [Google Scholar]
- LARAGH J. H., CANNON P. J., AMES R. P. INTERACTION BETWEEN ALDOSTERONE SECRETION, SODIUM AND POTASSIUM BALANCE, AND ANGIOTENSIN ACTIVITY IN MAN: STUDIES IN HYPERTENSION AND CIRRHOSIS. Can Med Assoc J. 1964 Jan 25;90:248–256. [PMC free article] [PubMed] [Google Scholar]
- LARAGH J. H. The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension. JAMA. 1960 Sep 17;174:293–295. doi: 10.1001/jama.1960.63030030007014. [DOI] [PubMed] [Google Scholar]
- LARAGH J. H., ULICK S., JANUSZEWICZ V., DEMING Q. B., KELLY W. G., LIEBERMAN S. Aldosterone secretion and primary and malignant hypertension. J Clin Invest. 1960 Jul;39:1091–1106. doi: 10.1172/JCI104124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LERNER B. A., BRICKENER P. W. Renal tubular acidosis and potassium loss. Am J Med. 1959 Oct;27:664–672. doi: 10.1016/0002-9343(59)90050-6. [DOI] [PubMed] [Google Scholar]
- LUETSCHER J. A., Jr, CURTIS R. H. Aldosterone: observations on the regulation of sodium and potassium balance. Ann Intern Med. 1955 Oct;43(4):658–666. doi: 10.7326/0003-4819-43-4-658. [DOI] [PubMed] [Google Scholar]
- MORAN W. H., Jr, ROSENBERG J. C., ZIMMERMANN B. The regulation of aldosterone output: significance of potassium ion. Surg Forum. 1958;9:120–122. [PubMed] [Google Scholar]
- MULLER A. F., MANNING E. L., RIONDEL A. M. L'excrétion de l'aldostérone chez le sujet normal pendant la déplétion et la réplétion en potassium. Helv Med Acta. 1958 Oct;25(4):547–551. [PubMed] [Google Scholar]
- MULROW P. J., GANONG W. F., CERA G., KULJIAN A. The nature of the aldosterone-stimulating factor in dog kidneys. J Clin Invest. 1962 Mar;41:505–518. doi: 10.1172/JCI104504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- VEYRAT R., DE CHAMPLAIN J., BOUCHER R., GENEST J. MEASUREMENT OF HUMAN ARTERIAL RENIN ACTIVITY IN SOME PHYSIOLOGICAL AND PATHOLOGICAL STATES. Can Med Assoc J. 1964 Jan 25;90:215–220. [PMC free article] [PubMed] [Google Scholar]